Stock Fundamentals

Company Information

Company Name
Abbott Laboratories
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
ISIN: US0028241000
CIK: 0000001800
CUSIP: 002824100
Currency: USD
Full Time Employees: 122,000
Phone: 224 667 6100
Fiscal Year End: December
IPO Date: Jan 13, 1978
Description:

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Address:

100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400

Directors & Officers

Name Title Year Born
Mr. Philip P. Boudreau CFO & Executive VP of Finance 1973
Mr. Daniel Gesua Sive Salvadori Executive VP and Group President of Established Pharmaceuticals & Nutritional Products 1979
Mr. Christopher J. Scoggins Executive Vice President of Diabetes Care 1970
Ms. Lisa D. Earnhardt Executive VP & Group President of Medical Devices 1970
Ms. Sabina Ewing Senior VP of Business & Technology Services and Chief Information Officer 1974
Mr. Michael Comilla Vice President of Investor Relations. NA
Erica L. Battaglia VP and Chief Ethics & Compliance Officer NA
Ms. Melissa Brotz Senior Vice President of Global Marketing & External Affairs NA
Ms. Mary K. Moreland Executive Vice President of Human Resources 1966
Mr. Scott Michael Leinenweber Senior Vice President of Licensing, Acquisitions & Ventures 1972

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 30, 2026 Ro Khanna N/A Sale N/A $101.85 N/A
Mar 24, 2026 Laura Friedman N/A Sale N/A $104.10 N/A
Mar 23, 2026 Ro Khanna N/A Purchase N/A $104.87 N/A
Mar 19, 2026 Richard McCormick N/A Purchase N/A $107.16 N/A
Mar 10, 2026 Ro Khanna N/A Purchase N/A $110.60 N/A
Mar 02, 2026 Daniel Gesua Sive Salvadori N/A Sale 885.00 $115.58 $102.29K
Mar 02, 2026 Elizabeth C Cushman N/A Sale 263.00 $115.58 $30.40K
Mar 02, 2026 Eric Shroff N/A Sale 709.00 $115.58 $81.95K
Mar 02, 2026 John A Jr. Mccoy N/A Sale 585.00 $115.58 $67.61K
Mar 02, 2026 Mary K Moreland N/A Sale 613.00 $115.58 $70.85K
Feb 27, 2026 Michael T. McCaul N/A Sale N/A $116.17 N/A
Feb 24, 2026 Ro Khanna N/A Purchase N/A $114.65 N/A
Feb 18, 2026 Ro Khanna N/A Sale N/A $113.32 N/A
Feb 17, 2026 Ro Khanna N/A Sale N/A $112.27 N/A
Feb 10, 2026 Gilbert Ray Cisneros, Jr. N/A Sale N/A $112.23 N/A
Feb 05, 2026 Michael T. McCaul N/A Purchase N/A $109.03 N/A
Feb 04, 2026 Daniel J Starks N/A Purchase 10.00K $108.73 $1.09M
Jan 29, 2026 Ro Khanna N/A Sale N/A $106.03 N/A
Jan 29, 2026 Thomas H. Kean, Jr. N/A Purchase N/A $106.03 N/A
Jan 23, 2026 Ro Khanna N/A Sale N/A $107.46 N/A

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 175.56M Dec 31, 2025 10.08% $0.32 1.39%
BlackRock Inc 145.69M Mar 31, 2026 8.36% $0.26 -0.83%
Vanguard Capital Management, LLC 112.95M Mar 31, 2026 6.48% $0.29 0.00%
State Street Corp 79.58M Mar 31, 2026 4.57% $0.28 -0.35%
Capital Research Global Investors 49.78M Mar 31, 2026 2.86% $0.79 27.08%
Vanguard Portfolio Management, LLC 47.94M Mar 31, 2026 2.75% $0.26 0.00%
Charles Schwab Investment Management Inc 45.50M Mar 31, 2026 2.61% $0.71 244.97%
Geode Capital Management, LLC 39.15M Mar 31, 2026 2.25% $0.25 1.93%
Capital Research & Mgmt Co - Division 3 37.50M Mar 31, 2026 2.15% $0.90 -40.70%
Morgan Stanley - Brokerage Accounts 30.10M Mar 31, 2026 1.73% $0.19 -18.04%
Wellington Management Company LLP 27.07M Mar 31, 2026 1.55% $0.52 15.51%
JPMorgan Chase & Co 26.77M Mar 31, 2026 1.54% $0.18 20.61%
NORGES BANK 23.46M Dec 31, 2025 1.35% $0.31 5.42%
Franklin Resources Inc 20.02M Mar 31, 2026 1.15% $0.50 79.50%
Northern Trust Corp 19.39M Mar 31, 2026 1.11% $0.26 -1.93%
Bank of America Corp 19.28M Mar 31, 2026 1.11% $0.14 -2.78%
T. Rowe Price Associates, Inc. 17.28M Mar 31, 2026 0.99% $0.21 17.38%
Wells Fargo & Co 15.91M Mar 31, 2026 0.91% $0.31 -2.31%
Massachusetts Financial Services Company 15.50M Mar 31, 2026 0.89% $0.54 6.75%
The Goldman Sachs Group Inc 14.51M Mar 31, 2026 0.83% $0.17 -6.39%

Shares Statistics

Shares Outstanding: 1.74B
Shares Float: 1.73B
% Insiders: 49.50%
% Institutions: 8,266.20%
Short % Float: 1.41%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 55.37M 3.18% ▲ 0.32% Apr 30, 2026
2 Vanguard 500 Index Investor 45.09M 2.59% ▲ 1.83% Apr 30, 2026
3 Schwab US Dividend Equity ETF™ 32.82M 1.88% ▲ 0.20% May 30, 2026
4 iShares Core S&P 500 ETF 22.91M 1.32% ▲ 0.31% May 29, 2026
5 Fidelity 500 Index 22.28M 1.28% ▲ 0.35% Apr 30, 2026
6 State Street® SPDR® S&P 500® ETF 20.97M 1.20% ▲ 0.11% May 31, 2026
7 Vanguard Value Index Inv 16.11M 0.92% ▲ 0.29% Apr 30, 2026
8 American Funds Washington Mutual A 16.01M 0.92% ▼ 18.67% Mar 31, 2026
9 Capital Group Wash Mutual Invtrs Comp 16.01M 0.92% ▼ 18.67% Mar 31, 2026
10 American Funds American Mutual A 12.38M 0.71% ▲ 6.30% Mar 31, 2026

Valuation Metrics

Enterprise Value: $180.35B
Trailing P/E: 24.70
Forward P/E: 16.10

Financial Highlights

Market Cap: $153.59B
EBITDA: $11.74B
P/E Ratio: $24.70
PEG Ratio: $1.31
Book Value: $29.89
Dividend/Share: $2.44
Dividend Yield: 2.72%
Earnings/Share: $3.57
Profit Margin: 13.90%
Operating Margin: 13.47%
ROA (TTM): 5.59%
ROE (TTM): 12.33%
Revenue (TTM): $45.13B
Revenue/Share (TTM): $25.91
Earnings Growth (YOY): -19.70%
Revenue Growth (YOY): 7.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.58x 0.25x 0.39x 23.60x 1.14x
2024-12-31 1.67x 0.30x 0.41x 11.32x 1.33x
2023-12-31 1.64x 0.39x 0.47x 9.22x 1.41x
2022-12-31 1.63x 0.46x 0.50x 26.55x 1.43x
2021-12-31 1.85x 0.51x 0.52x 22.44x 1.50x
2020-12-31 1.72x 0.58x 0.55x 7.47x 2.11x
2019-12-31 1.44x 0.59x 0.54x 5.61x 2.32x
2018-12-31 1.62x 0.64x 0.54x 5.27x 2.84x
2017-12-31 2.26x 0.90x 0.59x 2.24x 4.55x
2016-12-31 4.02x 1.07x 0.58x 10.69x 7.17x
2015-12-31 1.54x 0.42x 0.45x 16.57x 1.86x
2014-12-31 1.45x 0.36x 0.45x 17.78x 1.89x
2013-12-31 2.02x 0.26x 0.41x 45.66x 1.82x
2012-12-31 2.36x 0.77x 0.60x 4.91x 5.86x
2011-12-31 1.54x 0.63x 0.59x 6.72x 1.66x
2010-12-31 1.29x 0.83x 0.61x 8.80x 2.07x
2009-12-31 1.79x 0.71x 0.56x 31.19x 1.73x
2008-12-31 1.47x 0.65x 0.59x 11.52x 1.39x
2007-12-31 1.54x 0.69x 0.55x 8.34x 1.77x
2006-12-31 0.94x 0.88x 0.61x 10.42x 2.92x
2005-12-31 1.54x 0.46x 0.51x 19.26x 1.07x
2004-12-31 1.57x 0.47x 0.50x 20.87x 1.21x
2003-12-31 1.35x 0.46x 0.51x 20.35x 1.43x
2002-12-31 1.30x 0.60x 0.56x 15.36x 1.49x
2001-12-31 1.06x 0.80x 0.61x 0.01x 1.66x
2000-12-31 1.72x 0.18x 0.44x 146.44x 0.37x
1999-12-31 1.42x 0.12x 0.49x N/A 0.23x
1998-12-31 1.12x 0.31x 0.57x N/A 0.45x
1997-12-31 1.00x 0.36x 0.59x N/A 0.50x
1996-12-31 1.03x 0.29x 0.57x N/A 0.42x
1995-12-31 1.12x 0.24x 0.53x N/A 0.36x
1994-12-31 1.12x 0.19x 0.52x N/A 0.29x
1993-12-31 1.16x 0.23x 0.52x N/A 0.35x
1992-12-31 1.16x 0.27x 0.52x N/A 0.47x
1991-12-31 1.30x 0.17x 0.49x N/A 0.28x
1990-12-31 1.23x 0.23x 0.49x N/A 0.38x
1989-12-31 1.52x 0.11x 0.44x N/A 0.20x
1988-12-31 1.63x 0.20x 0.49x N/A 0.36x
1987-12-31 1.45x 0.29x 0.52x N/A 0.49x
1986-12-31 1.45x 0.33x 0.54x N/A 0.55x
1985-12-31 2.13x 0.07x 0.46x N/A 0.14x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ABT.US!